Role of ventral striatal dopamine D1 receptor in cigarette craving

Biol Psychiatry. 2007 Jun 1;61(11):1252-9. doi: 10.1016/j.biopsych.2006.06.028. Epub 2006 Aug 30.

Abstract

Background: Several theories of cigarette craving suggest that dopaminergic function in the ventral striatum plays an important role. The objective of this study was to determine correlations between craving-related brain activation and dopamine D1 receptor (D1R) binding in smokers.

Methods: Twelve smokers and 12 nonsmoking controls underwent [(15)O]H(2)O-positron emission tomography activation study and D1R-binding study using [(11)C]SCH 23390, and the correlations between receptor binding and cue-induced regional cerebral blood flow (rCBF) changes were assessed. Consecutive D1R-binding changes were examined during a period of 6 months of postsmoking abstinence in five smokers.

Results: Cue-induced activation was observed in the left ventral striatum including the nucleus accumbens in smokers. D1R binding in the ventral striatum showed a negative relationship with cue-induced craving and rCBF changes. D1R binding was significantly low in smokers, and there was a trend of increase after smoking abstinence.

Conclusions: D1R binding and cue-induced rCBF changes in the ventral striatum suggest the important role of D1R in this region in cigarette craving.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Benzazepines
  • Cerebrovascular Circulation / physiology
  • Cues
  • Data Interpretation, Statistical
  • Dopamine Antagonists
  • Functional Laterality / physiology
  • Humans
  • Male
  • Neostriatum / blood supply
  • Neostriatum / diagnostic imaging
  • Neostriatum / metabolism*
  • Radionuclide Imaging
  • Receptors, Dopamine D1 / genetics*
  • Smoking / genetics*
  • Smoking / psychology*
  • Smoking Cessation / psychology
  • Substance Withdrawal Syndrome / diagnostic imaging
  • Substance Withdrawal Syndrome / genetics
  • Substance Withdrawal Syndrome / psychology

Substances

  • Benzazepines
  • Dopamine Antagonists
  • Receptors, Dopamine D1